| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | super elongation complex | 3.61e-05 | 6 | 33 | 2 | GO:0032783 | |
| Domain | TF_AF4/FMR2 | 1.81e-05 | 4 | 33 | 2 | IPR007797 | |
| Domain | AF-4 | 1.81e-05 | 4 | 33 | 2 | PF05110 | |
| Domain | ARM-type_fold | 2.99e-04 | 339 | 33 | 5 | IPR016024 | |
| Domain | FA58C | 6.23e-04 | 21 | 33 | 2 | SM00231 | |
| Domain | FA58C_3 | 6.23e-04 | 21 | 33 | 2 | PS50022 | |
| Domain | FA58C_1 | 6.23e-04 | 21 | 33 | 2 | PS01285 | |
| Domain | FA58C_2 | 6.23e-04 | 21 | 33 | 2 | PS01286 | |
| Domain | F5_F8_type_C | 8.15e-04 | 24 | 33 | 2 | PF00754 | |
| Domain | FA58C | 8.15e-04 | 24 | 33 | 2 | IPR000421 | |
| Domain | - | 5.73e-03 | 207 | 33 | 3 | 1.25.40.10 | |
| Domain | - | 7.36e-03 | 73 | 33 | 2 | 2.60.120.260 | |
| Domain | TPR-like_helical_dom | 7.94e-03 | 233 | 33 | 3 | IPR011990 | |
| Domain | Galactose-bd-like | 1.20e-02 | 94 | 33 | 2 | IPR008979 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 26007649 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 37528066 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 24843025 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 10588740 | ||
| Pubmed | Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice. | 5.23e-06 | 4 | 33 | 2 | 11923441 | |
| Pubmed | A Minor Subset of Super Elongation Complexes Plays a Predominant Role in Reversing HIV-1 Latency. | 5.23e-06 | 4 | 33 | 2 | 26830226 | |
| Pubmed | Importance of a specific amino acid pairing for murine MLL leukemias driven by MLLT1/3 or AFF1/4. | 5.23e-06 | 4 | 33 | 2 | 25282333 | |
| Pubmed | Mediation of Af4 protein function in the cerebellum by Siah proteins. | 5.23e-06 | 4 | 33 | 2 | 15459319 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 1.20e-05 | 552 | 33 | 6 | 10737800 | |
| Pubmed | The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin. | 1.83e-05 | 7 | 33 | 2 | 15856011 | |
| Pubmed | 2.44e-05 | 8 | 33 | 2 | 32479599 | ||
| Pubmed | 2.73e-05 | 378 | 33 | 5 | 34315543 | ||
| Pubmed | 3.13e-05 | 9 | 33 | 2 | 24565118 | ||
| Pubmed | 3.91e-05 | 10 | 33 | 2 | 20153263 | ||
| Pubmed | 4.78e-05 | 11 | 33 | 2 | 20471949 | ||
| Pubmed | 4.78e-05 | 11 | 33 | 2 | 24367103 | ||
| Pubmed | The little elongation complex regulates small nuclear RNA transcription. | 5.73e-05 | 12 | 33 | 2 | 22195968 | |
| Pubmed | Transcriptional and posttranscriptional regulation of HIV-1 gene expression. | 6.77e-05 | 13 | 33 | 2 | 22355797 | |
| Pubmed | 7.89e-05 | 14 | 33 | 2 | 25921070 | ||
| Pubmed | 7.89e-05 | 14 | 33 | 2 | 20854876 | ||
| Pubmed | 1.18e-04 | 17 | 33 | 2 | 32548123 | ||
| Pubmed | Lost in transcription: molecular mechanisms that control HIV latency. | 1.48e-04 | 19 | 33 | 2 | 23518577 | |
| Pubmed | 1.99e-04 | 22 | 33 | 2 | 16024815 | ||
| Pubmed | The Role of RNA Polymerase II Elongation Control in HIV-1 Gene Expression, Replication, and Latency. | 1.99e-04 | 22 | 33 | 2 | 22567366 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 4.17e-04 | 1489 | 33 | 7 | 28611215 | |
| Pubmed | 4.87e-04 | 1084 | 33 | 6 | 11544199 | ||
| Pubmed | 5.39e-04 | 36 | 33 | 2 | 22626734 | ||
| Pubmed | USP1 deubiquitinates Akt to inhibit PI3K-Akt-FoxO signaling in muscle during prolonged starvation. | 5.69e-04 | 37 | 33 | 2 | 32133736 | |
| Pubmed | 5.91e-04 | 173 | 33 | 3 | 36217029 | ||
| Pubmed | Characterization of the DOT1L network: implications of diverse roles for DOT1L. | 7.00e-04 | 41 | 33 | 2 | 20431927 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 1.01e-05 | 4 | 24 | 2 | 1145 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 6.05e-05 | 9 | 24 | 2 | 1280 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.01e-02 | 115 | 24 | 2 | 769 | |
| ToppCell | severe-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.35e-05 | 198 | 33 | 4 | 3c4820a8391088682fb3e47b914f872533bae227 | |
| ToppCell | Sepsis-Int-URO-Others-RBC|Int-URO / Disease, condition lineage and cell class | 1.35e-05 | 198 | 33 | 4 | 29203aaa5c1844f72289e03f585cd5e7fc498a9a | |
| ToppCell | Sepsis-Int-URO-Others|Int-URO / Disease, condition lineage and cell class | 1.35e-05 | 198 | 33 | 4 | 67f721ea8e60042317ba12efd584f56b07cfb29d | |
| ToppCell | severe-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.37e-05 | 199 | 33 | 4 | 6ee4c2e6049860071169366b7e662d5c1a3cc54b | |
| ToppCell | COVID-19-COVID-19_Mild-Others-HSPC|COVID-19_Mild / Disease, condition lineage and cell class | 1.37e-05 | 199 | 33 | 4 | 0230103c37ae3aff58240739b89f2c36b1e39a69 | |
| ToppCell | MS-IIF-Others-HSPC|IIF / Disease, condition lineage and cell class | 1.37e-05 | 199 | 33 | 4 | 3384db80f6024bcabe2625f24d5f4e0d3d8caa7e | |
| ToppCell | MS-Multiple_Sclerosis-Others-HSPC|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.37e-05 | 199 | 33 | 4 | 7f4a22207a8b27af9a070d289e31ebd0e57af1a6 | |
| ToppCell | NS-critical-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.63e-04 | 144 | 33 | 3 | 0fde5cd82df9b90aefde19275cff6c2ec3c9d5cb | |
| ToppCell | IIF-Lymphocyte-T_NK-dnT|IIF / Disease, Lineage and Cell Type | 1.70e-04 | 146 | 33 | 3 | d0f361662db5f7be26104346e8431f7e30c5ce3a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-04 | 153 | 33 | 3 | 83942ef63d21725fa15ed5a91481d1f9936e8f11 | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.07e-04 | 156 | 33 | 3 | d9d87368e43b24952e70f31f38425e15b716ff5b | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-pDCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.15e-04 | 158 | 33 | 3 | 2af7beb48272e5368d9ba6b80f08d47ab8556c08 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.23e-04 | 160 | 33 | 3 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.23e-04 | 160 | 33 | 3 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-CD163+_Macrophage|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.23e-04 | 160 | 33 | 3 | 4480a7d6bd48d06b4e5196faac868f31ab7ed3ad | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.31e-04 | 162 | 33 | 3 | 86a0b9dabd150dc993bfc0f3344804de7f8e4042 | |
| ToppCell | NS-moderate-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.39e-04 | 164 | 33 | 3 | 35c673380f75cb4bfe080089bc723c4373bcc7a5 | |
| ToppCell | Mild-Myeloid-Mast-|Mild / Condition, Lineage, Cell class and cell subclass | 2.44e-04 | 165 | 33 | 3 | 93d3909a0f5f43d473d5005c842d7d73e25eceed | |
| ToppCell | NS-critical-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.44e-04 | 165 | 33 | 3 | 17d5c4a111d9b5400780bc5e7b93ce2f5d69ceb7 | |
| ToppCell | Mild-Myeloid-Mast|Mild / Condition, Lineage, Cell class and cell subclass | 2.44e-04 | 165 | 33 | 3 | 5fa9552c37890c5cc7e672a47038aebba2413cb4 | |
| ToppCell | 343B-Lymphocytic-ILC|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.48e-04 | 166 | 33 | 3 | a54377c703efff42d2cc1a8fdb610facc58053dd | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 2.52e-04 | 167 | 33 | 3 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.57e-04 | 168 | 33 | 3 | 968405ea56f7d001ef83ff9274610923c3b2d55d | |
| ToppCell | B_cells-pDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.57e-04 | 168 | 33 | 3 | dc8f94424f60ab56facdcffa969e7f3466ee1b6e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.66e-04 | 170 | 33 | 3 | 92e765ae0d3adb38d3b22fddb873fd5ccad3fd44 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.66e-04 | 170 | 33 | 3 | 9f8b215caa1afa3cd7104c06fca7cfd790640f66 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.66e-04 | 170 | 33 | 3 | b49f7c8a27078de2137ed04f74cfee30729cfa5e | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 2.66e-04 | 170 | 33 | 3 | 59cb1262ff319349d42b11afbec2a9035b7b79f2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-04 | 171 | 33 | 3 | 4fd2c7977c512c51507f055fc74b111c0228ed8b | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.71e-04 | 171 | 33 | 3 | 779c951d274ecbd1d546ac425d6c8e718623be5a | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.71e-04 | 171 | 33 | 3 | debbb071d260639b16269c94d172766908325c58 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-eo/baso/mast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.75e-04 | 172 | 33 | 3 | 7fb43b3938b9a3b6935ec22d9d853e7d47b82b3c | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.80e-04 | 173 | 33 | 3 | 1e4afa020fae682521335b440ccd33c16f37156f | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Eosinophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.80e-04 | 173 | 33 | 3 | a85cead231e03945fabbc7762540ad21fe4299df | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-pDC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.90e-04 | 175 | 33 | 3 | 37c2d4e0b6e9a3171931797ce9a54f3347288e57 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.90e-04 | 175 | 33 | 3 | 97fe431f224b592b3076632d101e19136c138dcc | |
| ToppCell | mild-Myeloid-pDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.95e-04 | 176 | 33 | 3 | 59a9c262c252b7d220a025837922d98e9d6b0a24 | |
| ToppCell | Control-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 2.95e-04 | 176 | 33 | 3 | 0c5916d63e1ada09105e46d2429b75129b7329ec | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.99e-04 | 177 | 33 | 3 | 507f06d31ab773099c9431b6f433899dc97b5566 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.99e-04 | 177 | 33 | 3 | 8887ff6341eb070bdaa890cc2cd7745f0cf1b0af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.04e-04 | 178 | 33 | 3 | 30d2b54462fd16222ad2e3806be6143e834b29e0 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-04 | 179 | 33 | 3 | 4808469096cd6bec2bdfcf4fc55aa324757600c3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.09e-04 | 179 | 33 | 3 | 124da6f882968dc0d05f3edd8f3b4d61617cc214 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-04 | 179 | 33 | 3 | c9f45cfea0ceb0cdc31bcfd123aeab69aeb35c35 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.09e-04 | 179 | 33 | 3 | edc5ef693dc4e7ea70717b77fb908fc784dce3a2 | |
| ToppCell | normal_Lung-B_lymphocytes|normal_Lung / Location, Cell class and cell subclass | 3.09e-04 | 179 | 33 | 3 | 5b89193486100b6754c1c5eca3105ea955805eae | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-04 | 179 | 33 | 3 | 4d55718c6afd8a038d93cc77b9b08171dab9976f | |
| ToppCell | RSV-Healthy-0|RSV / Virus stimulation, Condition and Cluster | 3.15e-04 | 180 | 33 | 3 | 974044056e2f7e909cb11c6f6ca89e58bf95f7e5 | |
| ToppCell | mild-Myeloid-pDC|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.15e-04 | 180 | 33 | 3 | 38614155fa537d0defda914c531c697be0ef06d8 | |
| ToppCell | moderate-Myeloid-pDC|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.15e-04 | 180 | 33 | 3 | a0751ad5e42a21cb107d900abfa9ee967a0069fc | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.15e-04 | 180 | 33 | 3 | 6a2366d76276452141db1bd93013a9503525f574 | |
| ToppCell | RSV-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 3.15e-04 | 180 | 33 | 3 | 703a1d0f9536af94d56757eb01221878d7b7fe61 | |
| ToppCell | NS-moderate-d_16-33-Myeloid-pDC|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.15e-04 | 180 | 33 | 3 | 144818e69613296cde43f29cb8c20899c670b319 | |
| ToppCell | 18-Airway-Immune-Hematopoietic,_B_Cells|Airway / Age, Tissue, Lineage and Cell class | 3.15e-04 | 180 | 33 | 3 | 200cecbd8c12a4ec334583fdd5057397504de71e | |
| ToppCell | Severe-Lymphoid-pDC|Severe / Condition, Lineage, Cell class and cell subclass | 3.20e-04 | 181 | 33 | 3 | 2caecb7c5dcdad46fd02b4ffb73cb613ce835187 | |
| ToppCell | tumor_Lung-Myeloid_cells-pDCs|tumor_Lung / Location, Cell class and cell subclass | 3.20e-04 | 181 | 33 | 3 | c864ffeb9234b8c29754afc91c85a972889617f4 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 181 | 33 | 3 | be7c7db6b99603759593e6f79cdcaa4bbf234cb7 | |
| ToppCell | Severe-Lymphoid-pDC-|Severe / Condition, Lineage, Cell class and cell subclass | 3.20e-04 | 181 | 33 | 3 | 277ce4c49121da0990a5933b19d2c6af9bbe253e | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.25e-04 | 182 | 33 | 3 | 6497eeafb2b137e70261ec0314782831892a940d | |
| ToppCell | Control-Hematopoietic_SC-HSPC|Control / Disease group, lineage and cell class | 3.25e-04 | 182 | 33 | 3 | 14e347c0e6444410f1948851407bb18c706569f4 | |
| ToppCell | Control-Hematopoietic_SC|Control / Disease group, lineage and cell class | 3.25e-04 | 182 | 33 | 3 | 43243c6bae2ac7fa3fd1f193a17f61ee4d938ea9 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 182 | 33 | 3 | c4a7007c864a9455a7e7447e28ccd380878a6a0f | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.25e-04 | 182 | 33 | 3 | d0ebf2f0d5370458ab81485a0017c311077133d5 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-pDC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.25e-04 | 182 | 33 | 3 | 02c0824373a0ecebc922d4ca848ace9d570722c4 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.25e-04 | 182 | 33 | 3 | 918286422b3eab32d962b49aa07b1b9512e51d9d | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.25e-04 | 182 | 33 | 3 | bd1626261803324084fafca2f6665b50854e7fae | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.25e-04 | 182 | 33 | 3 | 2a6d1246bfb5899a0861c7f2f8fb9b43b0df8acc | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 182 | 33 | 3 | c315d820ffad912c014ba5eac6f5fa6de1a94384 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.25e-04 | 182 | 33 | 3 | 0d9b8c900da8cbae9cde72aecd4026b1ac2bbd67 | |
| ToppCell | hematopoetic_progenitors-CD34+_MEP_2|World / Lineage and Cell class | 3.25e-04 | 182 | 33 | 3 | a7e7aa10f14111a6c7ba22e0f1668dcaa124714d | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-04 | 183 | 33 | 3 | 905e1e9be0f15be184447df04b134a6aa8279074 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-04 | 183 | 33 | 3 | 92eed783347a372b850de3189e72525082390014 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-04 | 183 | 33 | 3 | ed1e0b07475f9951728682ed70b85367cf2a744d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.30e-04 | 183 | 33 | 3 | df6fd0927b6e4cf9a1583969a68096e4bccfbace | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.30e-04 | 183 | 33 | 3 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-04 | 183 | 33 | 3 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-04 | 183 | 33 | 3 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | normal_Lung-B_lymphocytes-GrB-secreting_B_cells|normal_Lung / Location, Cell class and cell subclass | 3.30e-04 | 183 | 33 | 3 | c930b957d16f9b0904b6c424acd914532e5cc137 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.30e-04 | 183 | 33 | 3 | 3b123571e10c132227aff65648b4b3c6acb4bd00 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_MEMP|bone_marrow / Manually curated celltypes from each tissue | 3.35e-04 | 184 | 33 | 3 | b81a2a95944cee8fec13d63dc0d95496e67aa937 | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-plasmacytoid_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.41e-04 | 185 | 33 | 3 | cc5152d3055375172bdf84f442b233c8fbd422b3 | |
| ToppCell | normal-na-Myeloid-plasmacytoid_dendritic_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.41e-04 | 185 | 33 | 3 | 3091870a5bf8ecb963e560b47c8502bae367416c | |
| ToppCell | Healthy_donor-pDC|Healthy_donor / disease group, cell group and cell class (v2) | 3.41e-04 | 185 | 33 | 3 | 7fbb55cbdb39bdecb6063c8ba9776ab06c2666e8 | |
| ToppCell | Bac-SEP-Myeloid-pDC|Bac-SEP / Disease, Lineage and Cell Type | 3.41e-04 | 185 | 33 | 3 | 3de50b2042f22b0fb62ff12c76d85cc67649a0bd | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_pDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.41e-04 | 185 | 33 | 3 | 308a98f111895071d8772bc010554471cc12fab2 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.46e-04 | 186 | 33 | 3 | 916f2aeea4989ba7a29e071e348a51010f010223 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-pDC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.46e-04 | 186 | 33 | 3 | d23c3318937492d7d665bec14253124c49181b5a | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.46e-04 | 186 | 33 | 3 | 0096a61b1841784c913752b4f3639200446cc02c | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.46e-04 | 186 | 33 | 3 | b70cd94c651b56dcf2e55554533a5f1130845390 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.46e-04 | 186 | 33 | 3 | 31df1eafa3010bc1be6fc4d4689f1393d69b6b13 | |
| ToppCell | PBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.46e-04 | 186 | 33 | 3 | eaa431ccd4cdd36fe06a44987603ec9979025aa8 | |
| ToppCell | Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 3.46e-04 | 186 | 33 | 3 | 330a4f669adea91ff9f2dff2de2210f5e3401e19 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.46e-04 | 186 | 33 | 3 | 9e159ad7289dcae2ec7ce655df746f46801b81d3 | |
| ToppCell | COVID-19_Severe-Myeloid-pDC|COVID-19_Severe / Disease group, lineage and cell class | 3.46e-04 | 186 | 33 | 3 | 3db5ed69d49e5d79f990aca0295ddce4c297a05c | |
| ToppCell | PBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.46e-04 | 186 | 33 | 3 | b95be984e308d4f9061274a35995ec558d434e74 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.46e-04 | 186 | 33 | 3 | 8f7949740286f64e034d1eb533ebc2c6f71ae966 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic-pDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.46e-04 | 186 | 33 | 3 | 45f66619e45d590c7365a51782d4ac46b7d31fde | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.46e-04 | 186 | 33 | 3 | 95c7318e521fb6aa02e244b1e81e6b2a62107756 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.46e-04 | 186 | 33 | 3 | 6345777847960c71a2ba3ce5a49c72c34ebd0e73 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.52e-04 | 187 | 33 | 3 | d3563bb087e476baea5b59389e4d34d0ff98cac5 | |
| Disease | response to risperidone | 7.82e-04 | 38 | 32 | 2 | GO_0097336 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 1.00e-03 | 43 | 32 | 2 | DOID:9261 (is_marker_for) | |
| Disease | response to statin | 1.69e-03 | 56 | 32 | 2 | GO_0036273 | |
| Disease | basophil measurement | 1.94e-03 | 60 | 32 | 2 | EFO_0803539 | |
| Disease | testosterone measurement | 2.22e-03 | 1275 | 32 | 6 | EFO_0004908 | |
| Disease | stomach cancer (is_implicated_in) | 2.78e-03 | 72 | 32 | 2 | DOID:10534 (is_implicated_in) | |
| Disease | monocyte measurement | 3.58e-03 | 82 | 32 | 2 | EFO_0803547 | |
| Disease | response to radiation | 4.12e-03 | 88 | 32 | 2 | GO_0009314 | |
| Disease | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | 5.32e-03 | 328 | 32 | 3 | EFO_0008377, EFO_0008378 | |
| Disease | lymphocyte percentage of leukocytes | 5.57e-03 | 665 | 32 | 4 | EFO_0007993 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 5.80e-03 | 105 | 32 | 2 | DOID:9352 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKVICEMKVEEEHTN | 36 | Q9NPJ3 | |
| MDETHVINQVKEDVC | 196 | Q9GZN1 | |
| CQVHMEMAQIEEDED | 426 | Q8IYW2 | |
| GDVSCVDEILKEMTH | 311 | Q9UHB7 | |
| CVVMDTEEDNKHVGH | 286 | A4D126 | |
| EEMDIKDFCTHEVEP | 156 | Q96DC9 | |
| HICGEDQIEDKMEVT | 636 | Q8NEZ4 | |
| EVHLCEVEGMEKFKD | 576 | Q16832 | |
| TEMEQCHVDAIVDTL | 81 | O60760 | |
| CQMDGEEIEVQKEVA | 121 | P47871 | |
| EMVVTEHVSDKEALG | 201 | Q9NQX7 | |
| VTCVDTMQEEEGDKG | 1181 | Q86XA9 | |
| VMDITDIIHGKVDDE | 326 | Q9H7D0 | |
| EKDLEVEFDSCMIEH | 1306 | Q9H799 | |
| MLAHKAEDEGIICVE | 361 | P09622 | |
| MEQLEAVIDGSEHCE | 661 | Q8WYK1 | |
| IKGAVNLHMEEEVED | 396 | P30304 | |
| VVIFDEAHNVEKMCE | 246 | Q9NZ71 | |
| DDLVACVESMHQVEE | 1811 | Q6YHU6 | |
| NTHKVEEEGEIVMVH | 386 | Q8TEU7 | |
| VECVMEQLEHMEENL | 51 | Q9BRT9 | |
| VVQCLLGMEKEHEVE | 1056 | Q9C0D5 | |
| LGMEKEHEVEVNGTD | 1061 | Q9C0D5 | |
| DGEICEKGTHKELME | 676 | Q96J65 | |
| NEVHCVEEILKEMTH | 351 | P51825 | |
| DVDCSEEVIKHLIMA | 821 | P53675 | |
| EQHLMCEEHEEEKIN | 121 | Q9BYV2 | |
| SIKMEVGIEDCLHIE | 161 | Q4G0F5 | |
| VSEKHMEEGVNVDEI | 31 | Q9P243 | |
| KMTEEEVETVLAGHE | 176 | P14649 | |
| EIVEKDCVKESGSHM | 156 | Q9NPD5 | |
| KEVEKTEGDMTVQCH | 2616 | Q6ZS81 | |
| KDLHECLEAAMIEGE | 331 | Q9UHP3 | |
| HVPEQGDEKVCMDVF | 1116 | Q8N9V7 |